Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Airway Diameter Study in COPD
NCT02172391Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2000
- Primary completion
- Aug 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Nov 2000; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02172391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172391.